NEOGENOMICS INC — Director's Dealing 2025

May 9, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-05-07

Reporting Person: KANOVSKY STEPHEN M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-07	Common Stock	P	4000	$7.7811	Acquired	40090	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (4269)	4269	Direct
Stock Option (Right to Buy)	$28.54	2027-05-28	Common Stock (3448)	3448	Direct
Stock Option (Right to Buy)	$40.90	2028-06-02	Common Stock (3714)	3714	Direct
Stock Option (Right to Buy)	$8.10	2029-06-10	Common Stock (13882)	13882	Direct
Stock Option (Right to Buy)	$14.82	2033-08-10	Common Stock (8353)	8353	Direct
Stock Option (Right to Buy)	$13.71	2034-06-01	Common Stock (8672)	8672	Direct
Restricted Stock Unit	$0		Common Stock (12254)	12254	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.